IRIS
BARBIERI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.283
AS - Asia 603
SA - Sud America 101
NA - Nord America 60
AF - Africa 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.057
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.259
SG - Singapore 265
CN - Cina 150
VN - Vietnam 116
BR - Brasile 64
US - Stati Uniti d'America 42
HK - Hong Kong 27
AR - Argentina 20
MX - Messico 16
BD - Bangladesh 8
IQ - Iraq 8
ID - Indonesia 7
RU - Federazione Russa 7
CO - Colombia 5
EC - Ecuador 5
NL - Olanda 4
CL - Cile 3
PK - Pakistan 3
VE - Venezuela 3
IL - Israele 2
JO - Giordania 2
OM - Oman 2
PL - Polonia 2
TR - Turchia 2
UA - Ucraina 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CA - Canada 1
DE - Germania 1
GB - Regno Unito 1
HU - Ungheria 1
IE - Irlanda 1
IN - India 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MQ - Martinica 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
PH - Filippine 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.057
Salva come PNG Salva come JPEG
Città #
Genova 8.444
Genoa 4.553
Vado Ligure 1.220
Rapallo 997
Singapore 105
Beijing 53
Ho Chi Minh City 41
Bordighera 33
Ashburn 29
Hong Kong 27
Hanoi 24
Haiphong 17
Mexico City 13
Tianjin 8
Biên Hòa 7
Hải Dương 6
São Paulo 6
Belo Horizonte 4
Amsterdam 3
Baghdad 3
Erbil 3
Milan 3
Thái Bình 3
Amman 2
Bismarck 2
Buenos Aires 2
Curitiba 2
Córdoba 2
Da Nang 2
Guayaquil 2
Laranjal Paulista 2
Lomas de Zamora 2
Lấp Vò 2
Medellín 2
Pekanbaru 2
Ribeirão Preto 2
San Bernardo 2
Seregno 2
Tashkent 2
Warsaw 2
Abu Dhabi 1
Ankara 1
Apia 1
Araure 1
Arica 1
As Sālimīyah 1
Asunción 1
Atibaia 1
Babahoyo 1
Bandar Seri Begawan 1
Barbacena 1
Bariloche 1
Barranquilla 1
Be'er Ya'aqov 1
Bella Vista 1
Belém 1
Bengaluru 1
Benito Juarez 1
Blantyre 1
Blumenau 1
Bogotá 1
Bolzano 1
Brasília 1
Budapest 1
Bulungan 1
Camanducaia 1
Camboriú 1
Campina Grande 1
Campo Grande 1
Campo Largo 1
Canela 1
Canguçu 1
Canoas 1
Casimiro de Abreu 1
Changsha 1
Cherkessk 1
Cidade Ocidental 1
Cipó 1
Culiacán 1
Dalian 1
Denver 1
Dhaka 1
Drogheda 1
Ensenada 1
Florence 1
General Trias 1
Glasgow 1
Goiânia 1
Gravataí 1
Guararema 1
Gujrat 1
Ha Long 1
Hefei 1
Heidelberg 1
Hortolândia 1
Houston 1
Ilhéus 1
Irkutsk 1
Itajubá 1
Itapetininga 1
Totale 15.696
Salva come PNG Salva come JPEG
Nome #
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects 242
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 219
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 217
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells 211
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 210
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 204
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity 190
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. 190
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells 189
Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma 185
Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors 184
In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors 184
Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors 183
Chemokines and chemokine receptors: New actors in neuroendocrine regulations 181
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current 181
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity 179
Antisense oligonucleotides as therapeutic agents. 175
Endometrial stem cells and human reproductive failure 174
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 173
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma 172
SDF1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent cytosolic tyrosine kinase, Pyk2. 172
Drug-repositioning opportunities for cancer therapy: Novel molecular targets for known compounds 170
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease 168
Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability 168
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? 167
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets 167
Differential efficacy of SSTR1, 2 and 5 agonists in the inhibition of C6 glioma growth in nude mice 167
1,4-bis(1-naphtyl)-2,3-dinitro-1,3 butadiene a novel anticancer compound effective against tumor cell lines characterized by different mechanisms of resistance. 167
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 166
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 163
Different response of human glioma tumor-initiating cells to EGFR kinase inhibitors. 159
Glioblastoma cancer stem cells: response to epidermal growth factor receptor kinase inhibitors 159
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures 159
Molecular pharmacology of malignant pleural mesothelioma: Challenges and perspectives from preclinical and clinical studies 157
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 156
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 154
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 154
Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of Phidianidine A as a new CXCR4 ligand exhibiting antagonist activity 153
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives 152
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 150
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature 149
Differential role of EGF and bFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensitivity 148
17{beta}-ESTRADIOL PROMOTES BREAST CANCER CELL PROLIFERATION INDUCING SDF-1-MEDIATED EGFR TRANSACTIVATION: REVERSAL BY GEFITINIB PRE-TREATMENT. 147
The phosphotyrosine phosphatase PTPh mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 147
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation 146
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas 146
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 146
Chronic lymphocytic leukemic (CLL) B cells express the HGF receptor (C-MET) and are supported in their survival by HGF-producing mesenchymal stromal cell 144
CXC receptors and chemokines expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation 144
Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer. 141
Expression of cyclin D1 correlates with malignancy in human ovarian tumours 141
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis 141
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity 140
Mutual influence of ROS, pH and CLIC1 membrane protein in the regulation of G1/S phase progression in human glioblastoma stem cells 140
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures 139
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study 137
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential 137
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment 137
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 135
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies 132
A liposomal formulation for inflammation targeting 132
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells 130
Antiproliferative effect of DNA polymerase antisense oligodeoxynucleotides on breast cancer cells. 128
Ruta graveolens water extract inhibits cell-cell network formation in human umbilical endothelial cells via MEK-ERK1/2 pathway 126
Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells 126
Amyloid-beta Protein Precursor Regulates Phosphorylation and Cellular Compartmentalization of Microtubule Associated Protein Tau 124
The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells 123
Antitumor activity of a new o rally active organotin compound: a preliminare study in murine tumor models 123
Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity 123
Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines. 122
The use of antisense oligodeoxynucleotides (aODNs) in immunopharmacology. 122
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells 121
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt 121
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 121
Novel Sigma Binding Site Ligands as Inhibitors of Cell Proliferation in Breast Cancer 120
Somatostatin receptor 1, 2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo: analysis of the intracellular pathways involved 120
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation 119
Somatostatin and somatostatin receptors 1, 2 and 5 selective agonists inhibit C6 glioma cell growth in vitro and in vivo: Analysis of activated intracellular pathways 119
Goat anti-human GM-CSF recognizes canine GM-CSF 119
Biomimetic vesicles for glioblastoma treatment 118
Control of gene expression by triplex forming oligonucleotides in human live cells. 118
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract 117
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells 117
Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas. 116
Chemosensitivity of glioblastoma cells during treatment with the organo-tin compound triethyltin (IV) lupinylsulfide hydrochloride. 114
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies 111
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects 111
Thymidine Labelling Index as prognostic factor in resected non-small cell lung cancer. 110
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target 107
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound 105
Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in Ovarian tumors 102
Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferaton and migration. 101
Expression of somatostatin receptors mRNA in human meningiomas and their implication in in vitro antiproliferative activity 101
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells 99
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits 97
Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases 94
null 94
Somatostatin receptors 1, 2 and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro, via a PTPh-dependent inhibition of ERK1/2. 94
Feasibility of Thymidine Labelling Index on fine needle aspirates from breast cancer: comparison with surgical samples. 94
Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment 93
Totale 14.460
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.490
article - articoli 48.525
book - libri 0
conference - conferenze 2.538
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 427
Totale 102.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021514 0 0 0 0 0 58 46 57 68 137 89 59
2021/20221.381 55 124 73 165 35 102 95 310 66 111 58 187
2022/20231.210 108 82 14 128 147 223 1 106 209 16 149 27
2023/2024897 49 85 21 103 55 192 76 50 41 29 70 126
2024/20253.088 111 180 100 243 391 346 278 614 117 128 261 319
2025/20262.476 626 137 581 446 618 68 0 0 0 0 0 0
Totale 16.400